Rattel; Benno

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rattel; Benno.The latest application filed is for "psma and cd3 bispecific t cell engaging antibody constructs".

Company Profile

4.12.15

Rattel; Benno - Munich DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific T cell engaging antibody constructs Grant 11,434,302 - Raum , et al. September 6, 2	2022-09-06
BCMA and CD3 bispecific T cell engaging antibody constructs Grant 11,352,433 - Raum , et al. June 7, 2	2022-06-07
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs App 20210070878 - Raum; Tobias ; et al.	2021-03-11
PSMA and CD3 bispecific T cell engaging antibody constructs Grant 10,781,264 - Raum , et al. Sept	2020-09-22
Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs App 20200048357 - Raum; Tobias ; et al.	2020-02-13
BCMA and CD3 bispecific T cell engaging antibody constructs Grant 10,301,391 - Raum , et al.	2019-05-28
Optimized Cross-species Specific Bispecific Single Chain Antibody Contructs App 20170349668 - Rattel; Benno ; et al.	2017-12-07
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs App 20170218079 - Raum; Tobias ; et al.	2017-08-03
Bispecific T Cell Engaging Antibody Constructs App 20170218078 - Raum; Tobias ; et al.	2017-08-03
Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs App 20170218077 - Raum; Tobias ; et al.	2017-08-03
Use Of Vitamin Pp Compounds App 20100227896 - Biedermann; Elfi ; et al.	2010-09-09
Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents Grant 7,320,993 - Biedermann , et al. January 22, 2	2008-01-22
Pyridyl alkane acid amides as cytostatics and immunosuppressives Grant 7,276,524 - Biedermann , et al. October 2, 2	2007-10-02
Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives App 20070219197 - Biedermann; Elfi ; et al.	2007-09-20
Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives Grant 7,241,745 - Biedermann , et al. July 10, 2	2007-07-10
Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives App 20070142377 - Biedermann; Elfi ; et al.	2007-06-21
Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents Grant 7,192,967 - Biedermann , et al. March 20, 2	2007-03-20
Use of pyridly amides as inhibitors of angiogenesis App 20060052419 - Biedermann; Elfi ; et al.	2006-03-09
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides Grant 6,903,118 - Biedermann , et al. June 7, 2	2005-06-07
New pyridyl alkane acid amides as cytostatics and immunosuppressives App 20040176605 - Biedermann, Elfi ; et al.	2004-09-09
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression App 20040029861 - Biedermann, Elfi ; et al.	2004-02-12
Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immuno-suppressives App 20040009967 - Biedermann, Elfi ; et al.	2004-01-15
Pyridyl alkane acid amides as cytostatics and immunosupressives App 20030162972 - Biedermann, Elfi ; et al.	2003-08-28
Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides Grant 6,593,344 - Biedermann , et al. July 15, 2	2003-07-15
Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy App 20020160968 - Biedermann, Elfi ; et al.	2002-10-31
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression Grant 6,451,816 - Biedermann , et al. September 17, 2	2002-09-17
Pyridyl alkane acid amides as cytostatics and immunosuppressives Grant 6,444,823 - Biedermann , et al. September 3, 2	2002-09-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.